Table 4.

Multivariable risks for CMV infection or CMV disease

Multivariable risks for CMV INFECTION (59/264 with CMV INFECTION)
Risk factor	HR (95% CI)	P-value
No CMVIG	3.4 (1.2, 9.5)	0.022
CMV status, vs. D−R−
D+R+	12.3 (2.9, 52.0)	<0.001
D+R−	9.2 (2.1, 39.2)	0.003
D−R+	8.6 (1.8, 39.8)	0.006
Transplant 1992–1994 versus 2003–2005	2.1 (1.1, 3.8)	0.022
Prophylaxis completed before CMV infection	0.32 (0.18, 0.56)	<0.001
Multivariable risks for CMV DISEASE (74/325 with CMV DISEASE)
Risk factor	HR (95% CI)	P-value
No CMVIG	1.4 (0.70, 2.6)	0.37
CMV status, verses D−R−
D+R+	4.9 (1.4, 16.9)	0.012
D+R−	6.0 (1.8, 19.8)	0.003
D−R+	2.0 (0.51, 8.0)	0.32
Single Lung Transplant versus all others	5.3 (1.8, 15.3)	0.002
Any induction therapy	1.8 (1.07, 2.9)	0.025
Transplant 1992–2002 versus 2003–2005	5.5 (1.9, 15.5)	0.001
Prophylaxis completed before CMV disease	0.52 (0.30, 0.90)	0.021